Rocuronium Bromide Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Feb 15, 2023.

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
65219-442-05
Dosage Form
Injection
Presentation
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05)
Initial Posting
Feb 15, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.